Características clínicas asociadas al hallazgo de cáncer de tiroides originado a partir de nódulos calientes en pacientes con hipertiroidismo: reporte de un caso y revisión sistemática de la literatura

Autores/as

  • Carlos Osorio Universidad de Cartagena https://orcid.org/0000-0002-9963-6505
  • Jorge Ballestas School of Medicine, Universidad de Cartagena, Cartagena, Colombia.
  • Diego Barrios School of Medicine, Universidad de Cartagena, Cartagena, Colombia. E.S.E.
  • Andrés Arévalo Hospital Universitario del Caribe, Cartagena, Colombia.
  • Shekyna Montaño Hospital Universitario del Caribe, Cartagena, Colombia.
  • Nashelly Pérez Hospital Universitario del Caribe, Cartagena, Colombia.
  • Yessica Guardo Hospital Universitario del Caribe, Cartagena, Colombia.
  • Hernán Oviedo Hospital Universitario del Caribe, Cartagena, Colombia.
  • Valeria Zambrano Hospital Universitario del Caribe, Cartagena, Colombia.
  • Katherine Redondo Hospital Universitario del Caribe, Cartagena, Colombia.
  • Francisco Herrera General Surgery Service, E.S.E. Hospital Universitario del Caribe, Cartagena, Colombia.

DOI:

https://doi.org/10.30944/20117582.790

Palabras clave:

glándula tiroides, neoplasias de la tiroides, hipertiroidismo, nódulo tiroideo, adenocarcino folicular, revisión sistemática

Resumen

La coexistencia entre cáncer de tiroides e hipertiroidismo es infrecuente, y la mayoría de las lesiones nodulares a partir de las cuales se documenta un tumor maligno en este grupo de pacientes corresponden a nódulos fríos. Justificado en el creciente número de reportes en la literatura acerca de tumores malignos diagnosticados a partir de nódulos calientes, se realizó una revisión sistemática que tuvo como objetivo determinar los posibles factores asociados con el diagnóstico de cáncer de tiroides a partir de nódulos calientes en pacientes con hipertiroidismo. Los resultados sugieren que el diagnóstico clínico de bocio nodular tóxico, lesiones nodulares de diámetro mayor de 10 mm y tipo histológico compatible con carcinoma folicular, son factores que aumentan por sí solos el riesgo de realizar el diagnóstico de cáncer a partir de un nódulo caliente.

Descargas

Los datos de descargas todavía no están disponibles.

Biografía del autor/a

Carlos Osorio, Universidad de Cartagena

Scalpellum Research Group. Professor, School of Medicine, Universidad de Cartagena, Cartagena, Colombia. Endocrine Surgery Group, General Surgery Service, E.S.E. Hospital Universitario del Caribe, Cartagena, Colombia.

Jorge Ballestas, School of Medicine, Universidad de Cartagena, Cartagena, Colombia.

Scalpellum Research Group. General Surgery Resident, School of Medicine, Universidad de Cartagena, Cartagena, Colombia.

Diego Barrios, School of Medicine, Universidad de Cartagena, Cartagena, Colombia. E.S.E.

Scalpellum Research Seedbed. Ungraduated Student, School of Medicine, Universidad de Cartagena, Cartagena, Colombia. E.S.E.
Hospital Universitario del Caribe, Cartagena, Colombia.

Andrés Arévalo, Hospital Universitario del Caribe, Cartagena, Colombia.

Scalpellum Research Seedbed. Ungraduated Student, School of Medicine, Universidad de Cartagena, Cartagena, Colombia. E.S.E. Hospital Universitario del Caribe, Cartagena, Colombia.

Shekyna Montaño, Hospital Universitario del Caribe, Cartagena, Colombia.

Scalpellum Research Seedbed. Ungraduated Student, School of Medicine, Universidad de Cartagena, Cartagena, Colombia. E.S.E. Hospital Universitario del Caribe, Cartagena, Colombia.

Nashelly Pérez, Hospital Universitario del Caribe, Cartagena, Colombia.

Scalpellum Research Seedbed. Ungraduated Student, School of Medicine, Universidad de Cartagena, Cartagena, Colombia. E.S.E. Hospital Universitario del Caribe, Cartagena, Colombia.

Yessica Guardo, Hospital Universitario del Caribe, Cartagena, Colombia.

Scalpellum Research Seedbed. Ungraduated Student, School of Medicine, Universidad de Cartagena, Cartagena, Colombia. E.S.E. Hospital Universitario del Caribe, Cartagena, Colombia.

Hernán Oviedo, Hospital Universitario del Caribe, Cartagena, Colombia.

Scalpellum Research Seedbed. Ungraduated Student, School of Medicine, Universidad de Cartagena, Cartagena, Colombia. E.S.E. Hospital Universitario del Caribe, Cartagena, Colombia.

Valeria Zambrano, Hospital Universitario del Caribe, Cartagena, Colombia.

Scalpellum Research Seedbed. Ungraduated Student, School of Medicine, Universidad de Cartagena, Cartagena, Colombia. E.S.E. Hospital Universitario del Caribe, Cartagena, Colombia.

Katherine Redondo, Hospital Universitario del Caribe, Cartagena, Colombia.

Scalpellum Research Group. Professor, School of Medicine, Universidad de Cartagena, Cartagena, Colombia. Pathological Anatomy Service, E.S.E. Hospital Universitario del Caribe, Cartagena, Colombia.

Francisco Herrera, General Surgery Service, E.S.E. Hospital Universitario del Caribe, Cartagena, Colombia.

Scalpellum Research Group. Professor, School of Medicine, Universidad de Cartagena, Cartagena, Colombia. Endocrine Surgery Group, General Surgery Service, E.S.E. Hospital Universitario del Caribe, Cartagena, Colombia.

Referencias bibliográficas

Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, et al. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid. 2016;26:1-133. https://doi.org/10.1089/thy.2015.0020

Pazaitou-Panayiotou K, Michalakis K, Paschke R. Thyroid cancer in patients with hyperthyroidism. Horm Metab Res. 2012;44:255-62. https://doi.org/10.1055/s-0031-1299741

Liu J, Wang Y, Da D, Zheng M. Hyperfunctioning thyroid carcinoma: A systematic review. Mol Clin Oncol. 2019;11:535-50. https://doi.org/10.3892/mco.2019.1927

Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JP, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med. 2009;6:e1000100. https://doi.org/10.1371/journal.pmed.1000100

Bitton RN, Sachmechi I, Tabriz MS, Murphy L, Wasserman P. Papillary carcinoma of the thyroid with manifestations resembling Graves’ disease. Endocr Pract. 2001;7:106-9. https://doi.org/10.4158/EP.7.2.106

Mazziotti G, Rotondi M, Manganella G, Franco R, Capone PF, Colantuoni V, et al. Medullary thyroid cancer, papillary thyroid microcarcinoma and Graves’ disease: an unusual clinical coexistence. J Endocrinol Invest. 2001;24:892-966. https://doi.org/10.1007/BF03343948

Mishra A, Mishra SK. Thyroid nodules in Graves’ disease: implications in an endemically iodine deficient area. J Postgrad Med. 2001;47:244-7.

Als C, Gedeon P, Rösler H, Minder C, Netzer P, Laissue JA. Survival analysis of 19 patients with toxic thyroid carcinoma. J Clin Endocrinol Metab. 2002;87:4122-7. https://doi.org/10.1210/jc.2001-011147

Basaria S, Salvatori R. Thyrotoxicosis due to metastatic papillary thyroid cancer in a patient with Graves’ disease. J Endocrinol Invest. 2002;25:639-42. https://doi.org/10.1007/BF03345090

Harach HR, Sánchez SS, Williams ED. Pathology of the autonomously functioning (hot) thyroid nodule. Ann Diagn Pathol. 2002;6:10-19. https://doi.org/10.1053/adpa.2002.30605

Newman SL, Griffith AY, Herbst AB, Yeh IT, Kukora JS. An unusual initial manifestation of metastatic papillary thyroid carcinoma: radioiodine uptake in lymph node metastatic lesions in a patient with Graves’ disease. Endocr Pract. 2002;8:304-6. https://doi.org/10.4158/EP.8.4.304

Stocker DJ, Foster SS, Solomon BL, Shriver CD, Burch HB. Thyroid cancer yield in patients with Graves’ disease selected for surgery on the basis of cold scintiscan defects. Thyroid. 2002;12:305-11. https://doi.org/10.1089/10507250252949432

Villar A, Zurro J, De Luis DA, Cuéllar L, Terroba C, Romero E. Acromegalia, bocio tóxico multinodular y carcinoma papilar de tiroides, probable papel de las proteínas G. An Med Interna. 2002;19:37-8. https://doi.org/10.4321/S0212-71992002000200007

Yaturu S, Fowler MR. Differentiated thyroid carcinoma with functional autonomy. Endocr Pract. 2002;8:36-9. https://doi.org/10.4158/EP.8.1.36

dell’Erba L, Gerundini P, Caputo M, Bagnasco M. Association of hyperfunctioning thyroid adenoma with thyroid cancer presenting as “trapping only” nodule at 99mTcO4- scintigraphy. J Endocrinol Invest. 2003;26:1124-7. https://doi.org/10.1007/BF03345262

Führer D, Tannapfel A, Sabri O, Lamesch P, Paschke R. Two somatic TSH receptor mutations in a patient with toxic metastasising follicular thyroid carcinoma and non-functional lung metastases. Endocr Relat Cancer. 2003;10:591-600. https://doi.org/10.1677/erc.0.0100591

Gabriele R, Letizia C, Borghese M, De Toma G, Celi M, Izzo L, et al. Thyroid cancer in patients with hyperthyroidism. Horm Res. 2003;60:79-83. https://doi.org/10.1159/000071875

Gerenova J, Buysschaert M, de Burbure CY, Daumerie C. Prevalence of thyroid cancer in Graves’ disease: a retrospective study of a cohort of 103 patients treated surgically. Eur J Intern Med. 2003;14:321-5. https://doi.org/10.1016/S0953-6205(03)00105-5

Lin C, Chiang F, Wang L. Prevalence of thyroid cancer in hyperthyroidism treated by surgery. Kaohsiung J Med Sci. 2003;19:379-384. https://doi.org/10.1016/S1607-551X(09)70480-2

Wong CP, AuYong TK, Tong CM. Thyrotoxicosis: a rare presenting symptom of Hurthle cell carcinoma of the thyroid. Clin Nucl Med. 2003;28:803-6. https://doi.org/10.1097/01.rlu.0000089667.15648.e9

Gozu H, Avsar M, Bircan R, Sahin S, Ahiskanali R, Gulluoglu B, et al. Does a Leu 512 Arg thyrotropin receptor mutation cause an autonomously functioning papillary carcinoma?. Thyroid. 2004;14:975-80. https://doi.org/10.1089/thy.2004.14.975

Majima T, Doi K, Komatsu Y, Itoh H, Fukao, Shigemoto M, et al. Papillary thyroid carcinoma without metastasis manifesting as an autonomously funtioning thyroid nodule. Endocrin J. 2005;52:309-16. https://doi.org/10.1507/endocrj.52.309

Sahin M, Guvener ND, Ozer F, Sengul A, Ertugrul D, Tutuncu NB. Thyroid cancer in hyperthyroidism: incidence rates and value of ultrasound-guided fine-needle aspiration biopsy in this patient group. J Endocrinol Invest. 2005;28:815-8. https://doi.org/10.1007/BF03347572

Taneri F, Kurukahvecioglu O, Ege B, Yilmaz U, Tekin EH, Cifter C, et al. Clinical presentation and treatment of hyperthyroidism associated with thyroid cancer. Endocr Regul. 2005;39:91-6.

Bitterman A, Uri O, Levanon A, Baron E, Lefel O, Cohen O. Thyroid carcinoma presenting as a hot nodule. Otolaryngol Head Neck Surg. 2006;134:888-9. https://doi.org/10.1016/j.otohns.2005.03.054

Cappelli C, Braga M, De Martino E, Castellano M, Gandossi E, Agosti B, et al. Outcome of patients surgically treated for various forms of hyperthyroidism with differentiated thyroid cancer: experience at an endocrine center in Italy. Surg Today. 2006;36:125-30. https://doi.org/10.1007/s00595-005-3115-3.

Niepomniszcze H, Suárez H, Pitoia F, Pignatta A, Danilowicz K, Manavela M, et al. Follicular carcinoma presenting as autonomous functioning thyroid nodule and containing an activating mutation of the TSH receptor (T620I) and a mutation of the Ki-RAS (G12C) genes. Thyroid. 2006;16:497-503. https://doi.org/10.1089/thy.2006.16.497

Ohno S, Yamamoto N, Asato R, Tanaka S, Ito J, Omori K, et al. Functioning Thyroid Papillary Carcinoma: A case report. Practica Oto-Rhino-Laryngologica. 2006;99:43-7. https://doi.org/10.5631/jibirin.99.43

Pucci A, Suppo M, Lucchesi G, Celeste A, Viberti L, Pellerito R, et al. Papillary thyroid carcinoma presenting as a solitary soft tissue arm metastasis in an elderly hyperthyroid patient. Case report and review of the literature. Virchows Arch. 2006;448:857-61. https://doi.org/10.1007/s00428-006-0187-4

Weber KJ, Solorzano CC, Lee JK, Gaffud MJ, Prinz RA. Thyroidectomy remains an effective treatment option for Graves’ disease. Am J Surg. 2006;191:400-5. https://doi.org/10.1016/j.amjsurg.2005.10.043

Cakir M, Arici C, Alakus H, Altunbas H, Balci MK, Karayalcin U. Incidental thyroid carcinoma in thyrotoxic patients treated by surgery. Horm Res. 2007;67:96-9. https://doi.org/10.1159/000096357

Casañ R, Gómez M, García K, Yanini J, Peña H, Muñoz ML, et al. Características clínicas, histológicas y evolutivas de una serie de 11 casos de cáncer diferenciado de tiroides con hipertiroidismo. Endocrinol Nutr. 2007;54:134-8. https://doi.org/10.1016/S1575-0922(07)71421-3

Cerci C, Cerci SS, Eroglu E, Dede M, Kapucuoglu N, Yildiz M, Bulbul M. Thyroid cancer in toxic and non-toxic multinodular goiter. J Postgrad Med 2007;53:157-60. https://doi.org/10.4103/0022-3859.33855

Kim TS, Asato R, Akamizu T, Harada D, Nakashima Y, Higashi T, et al. A rare case of hyperfunctioning papillary carcinoma of the thyroid gland. Acta Otolaryngol. 2007;127:55-7. https://doi.org/10.1080/03655230601066785

Makarewicz J, Mikosiński S, Rutkowski A, Adamczewski Z, Lewiński A. Graves’ thyrotoxicosis in a patient with metastatic differentiated thyroid carcinoma and chronic lymphocytic leukaemia. Arch Med Sci. 2007;3: 179-84.

Yano Y, Shibuya H, Kitagawa W, Nagahama M, Sugino K, Ito K, et al. Recent outcome of Graves’ disease patients with papillary thyroid cancer. Eur J Endocrinol. 2007;157:325-9. https://doi.org/10.1530/EJE-07-0136

Cross GA, Suarez H, Pitoia F, Moncet D, Venegas M, Niepomniszcze, et al. Fatal outcome of a young woman with papillary thyroid carcinoma and graves’ disease: possible implication of “cross-signalling” mechanism. Arq Bras Endocrinol Metabol. 2008;52:1194-200. https://doi.org/10.1590/S0004-27302008000700018

Dănilă R, Karakas E, Osei-Agyemang T, Hassan I. Outcome of incidental thyroid carcinoma in patients undergoing surgery for Graves’ disease. Rev Med Chir Soc Med Nat Iasi. 2008;112:115-8.

Erbil Y, Barbaros U, Ozbey N, Kapran Y, Tükenmez M, Bozbora A, et al. Graves’ disease, with and without nodules, and the risk of thyroid carcinoma. J Laryngol Otol. 2008;122:291-5. https://doi.org/10.1017/S0022215107000448

Mssrouri R, Benamr S, Essadel A, Mdaghri J, Mohammadine E, Lahlou M, et al. Maladie de Basedow et cancers différenciés de la thyroïde. J Chir. 2008;145:244-6. https://doi.org/10.1016/S0021-7697(08)73753-0

Nishida AT, Hirano S, Asato R, Tanaka S, Kitani Y, Honda N, et al. Multifocal hyperfunctioning thyroid carcinoma without metastases. Auris Nasus Larynx. 2008;35:432-6. https://doi.org/10.1016/j.anl.2007.07.008

Phitayakorn R, McHenry C. Incidental thyroid carcinoma in patients whit Graves’ disease. AJS. 2008;195:292-7. https://doi.org/10.1016/j.amjsurg.2007.12.006

Senyurek Giles Y, Tunca F, Boztepe H, Kapran Y, Terzioglu T, Tezelman S. The risk factors for malignancy in surgically treated patients for Graves’ disease, toxic multinodular goiter, and toxic adenoma [published correction appears in Surgery. 2009 Sep;146:482.

Uludag M, Yetkin G, Citgez B, Isgor A, Basak T. Autonomously functioning thyroid nodule treated with radioactive iodine and later diagnosed as papillary thyroid cancer. Hormones. 2008;7:175-9. https://doi.org/10.1007/BF03401510

Basu S, Moghe SH, Shet T, Borges AM. A nonpalpable toxic thyroid lobe besides a malignant lobe. Hell J Nucl Med. 2009;12:173-4.

Wang CY, Chang TC. Toxic nodular goiter with thyroid papillary microcarcinoma. ANZ J Surg. 2010;80:117. https://doi.org/10.1111/j.1445-2197.2009.05193.x

Azevedo MF, Casulari LA. Hyperfunctioning thyroid cancer: a five-year follow-up. Arq Bras Endocrinol Metabol. 2010;54:78-80. https://doi.org/10.1590/S0004-27302010000100013

Bommireddipalli S, Goel S, Gadiraju R, Paniz-MondolFi A, DePuey EG. Follicular variant of papillary thyroid carcinoma presenting as a toxic nodule by I-123 scintigraphy. Clin Nucl Med. 2010;35:770-5. https://doi.org/10.1097/RLU.0b013e3181e4dc7f

Giovanella L, Fasolini F, Suriano S, Mazzucchelli L. Hyperfunctioning solid/trabecular follicular carcinoma of the thyroid gland. J Oncol. 2010;2010:635984. https://doi.org/10.1155/2010/635984

Hernán-Martínez J, Uzcategui M, Corder E, Castillo M, Sostre S, Alicea L. Hyperthyroidism, hyperfunctioning thyroid nodule, and thyroid cancer in a young female: a rare and unusual coexistence. P R Health Sci J. 2010;29:78-82.

Nunes Vdos S, Tagliarini JV, Marques ME, de Godoi JA, Mazeto GM. A patient with Graves’ disease and three types of thyroid carcinoma. Thyroid. 2010;20:573-4. https://doi.org/10.1089/thy.2008.0330

Tfayli HM, Teot LA, Indyk JA, Witchel SF. Papillary thyroid carcinoma in an autonomous hyperfunctioning thyroid nodule: case report and review of the literature. Thyroid. 2010;20:1029-32. https://doi.org/10.1089/thy.2010.0144

Berker D, Isik S, Ozuguz U, Tutuncu Y, Kucukler K, Akbaba G, et al. Prevalence of incidental thyroid cancer and its ultrasonographic features in subcentimeter thyroid nodules of patients with hyperthyroidism. Endocr. 2011;39:13-20. https://doi.org/10.1007/s12020-010-9405-6

Ciarallo A, Makis W, Novales-Diaz JA. Incidental papillary thyroid carcinoma in a patient presenting with Graves’ hyperthyroidism and concomitant obstructive sequestered intrathoracic multinodular goiter. Clin Nucl Med. 2011;36:145-7. https://doi.org/10.1097/RLU.0b013e318203bcc6

Polyzos SA, Goulis DG. Coincidental thyroid papillary microcarcinoma in a patient treated for a toxic adenoma of the thyroid. Arch Iran Med. 2011;14:149-51. 56. Yalla NM, Reynolds LR. Hürthle cell thyroid carcinoma presenting as a “hot” nodule. Endocr Pract. 2011;17:e68-e72. https://doi.org/10.4158/EP10334.CR

Zivaljevic V, Zivic R, Diklic A, Krgovic K, Kalezic N, Vekic B, et al. Unifokale hyperfunktionelle Karzinome der Schilddrüse [Solitary hyperfunctioning thyroid gland carcinomas]. Zentralbl Chir. 2011;136:374-8. https://doi.org/10.1055/s-0030-1262541

Karanchi H, Hamilton DJ, Robbins RJ. Hürthle cell carcinoma of the thyroid presenting as thyrotoxicosis. Endocr Pract. 2012;18:e5-e9. https://doi.org/10.4158/EP11142.CR

Nair CG, Jacob P, Babu M, Menon R. Toxic thyroid carcinoma: A new case. Indian J Endocrinol Metab. 2012;16:668-70. https://doi.org/10.4103/2230-8210.98047

Polat SB, Er M, Önal ED, Ersoy R, Çakır B. Graves’ Disease and Papillary Thyroid Carcinoma in a Patient with Active Sarcoidosis. Türk Jem. 2012;16:72-4. https://doi.org/10.4274/Tjem.2042

Rehman RA, Nyenwe E. Papillary thyroid carcinoma in a toxic adenoma. JIM. 2012;60:350-1.

Resch T, Sucher R, Wimmer G, Hauck A, Fussenegger D, Stromberger K, et al. Is Grave’s disease a risk factor for thyroid carcinoma?. Eur Surg. 2012;44:104.

Anastasilakis AD, Ruggeri RM, Polyzos SA, Makras P, Molyva D, Campennì A, et al. Coexistence of Graves’ disease, papillary thyroid carcinoma and unilateral benign struma ovarii: case report and review of the literature. Metabolism. 2013;62:1350-6. https://doi.org/10.1016/j.metabol.2013.05.013

Calimon M, Lim U. Papillary thyroid carcinoma with lymphocytic thyroiditis in an autonomous hyperfunctioning thyroid nodule. Eur Thyroid J. 2013;2:125.

Chinchuk I, Sleptsov I, Isheiskaya M, Chernikov R, Semenov A, Makarin V, et al. Thyroid cancer in graves disease patients. Eur Thyroid J. 2013;2:164.

Grigorovici A,Velicescu C, Costache M, Ciobanu D. The incidence of thyroid cancer in patients whit Graves’ disease. Langenbecks Arch Surg. 2013;398:767.

Mirfakhraee S, Mathews D, Peng L, Woodruff S, Zigman JM. A solitary hyperfunctioning thyroid nodule harboring thyroid carcinoma: review of the literature. Thyroid Res. 2013;6:7. https://doi.org/10.1186/1756-6614-6-7

Ngalob QG, Isip-Tan IT. Thyroid cancer in Plummer’s disease. BMJ Case Rep. 2013;2013:bcr201300890. https://doi.org/10.1136/bcr-2013-008909

Pacenza N, Groppo N, Guibourg H. Asociación de carcinoma papilar de tiroides y enfermedad de Graves. Inesperada evolución y eficacia de la dosis ablativa con tirotrofina recombinante humana (rhTSH). Rev Argent Endocrinol Metab. 2013;50:35-41.

Ruggeri RM, Campennì A, Giovinazzo S, Saraceno G, Vicchio TM, Carlotta D, et al. Follicular variant of papillary thyroid carcinoma presenting as toxic nodule in an adolescent: coexistent polymorphism of the TSHR and Gsα genes. Thyroid. 2013;23:239-42. https://doi.org/10.1089/thy.2012.0279.

Zahn A, Kußmann J. Thyroid cancer in patients with Graves’ disease. Langenbecks Arch Surg. 2013; 398:769.

Ergin AB, Saralaya S, Olansky L. Incidental papillary thyroid carcinoma: clinical characteristics and prognostic factors among patients with Graves’ disease and euthyroid goiter, Cleveland Clinic experience. Am J Otolaryngol. 2014;35:784-90. https://doi.org/10.1016/j.amjoto.2014.04.013

Gabalec F, Svilias I, Plasilova I, Hovorkova E, Ryska A, Horacek J. Follicular variant of papillary carcinoma presenting as a hyperfunctioning thyroid nodule. J Pediatr Hematol Oncol. 2014;36:e94-e96. https://doi.org/10.1097/MPH.0000000000000036.

He Y, Liu S, Guo H, Shi B. Incidental finding of papillary thyroid carcinoma with BRAFV600E mutation in a patient with coexistent primary hyperparathyroidism and Graves’ hyperthyroidism. BMJ Case Rep. 2014;2014:bcr2013203436. https://doi.org/10.1136/bcr-2013-203436

Kuan Y, Florence H. Thyroid papillary carcinoma in a “hot” thyroid nodule. Q J Med. 2014;107:475-6. https://doi.org/10.1093/qjmed/hct204

Preece J, Grodski S, Yeung M, Bailey M, Serpell J. Thyrotoxicosis does not protect against incidental papillary thyroid cancer. Surgery. 2014;156:1153-6. https://doi.org/10.1016/j.surg.2014.04.025

Ren M, Wu MC, Shang CZ, Wang XY, Zhang JL, Cheng H, et al. Predictive factors of thyroid cancer in patients with Graves’ disease. World J Surg. 2014;38:80-7. https://doi.org/10.1007/s00268-013-2287-z

Tam AA, Kaya C, Kılıç FB, Ersoy R, Çakır B. Thyroid nodules and thyroid cancer in Graves’ disease. Arq Bras Endocrinol Metabol. 2014;58:933-8. https://doi.org/10.1590/0004-2730000003569

Tamatea JA, Tu’akoi K, Conaglen JV, Elston MS, Meyer-Rochow GY. Thyroid cancer in Graves’ disease: is surgery the best treatment for Graves’ disease? ANZ J Surg. 2014;84:231-4. https://doi.org/10.1111/j.1445-2197.2012.06233.x

Campennì A, Giovinazzo S, Curtò L, Giordano E, Trovato M, Ruggeri RM, et al. Thyroid hemiagenesis, Graves’ disease and differentiated thyroid cancer: a very rare association: case report and review of literature. Hormones. 2015;14:451-8. https://doi.org/10.14310/horm.2002.1606

Kunjumohamed FP, Al-Busaidi NB, Al-Musalhi HN, Al-Shereiqi SZ, Al-Salmi IS. The prevalence of thyroid cancer in patients with hyperthyroidism. Saudi Med J. 2015;36:874-7. https://doi.org/10.15537/smj.2015.7.11463

Padma S, Sundaram PS, Arun BR. Unusual presentation of Warthin variant of Papillary thyroid carcinoma with lymph nodal metastases in a patient of Graves’ disease. J Cancer Res Ther. 2015;11:652. https://doi.org/10.4103/0973-1482.138041.

Patil M, Kamalanathan S, Sahoo J, Vivekanandan M, Kate V, Pandit N, et al. Papillary thyroid microcarcinoma in Graves’ disease presenting as a cystic neck mass. J Cancer Res Ther. 2015;11:986-8. https://doi.org/10.4103/0973-1482.157316

Tastan B, Dogu A, Sevim Y. Thyroid cancer in patients whit hyperthyroidism. WJOES. 2015;7:29-32. https://doi.org/10.5005/jp-journals-10002-1162

Wei S, Baloch ZW, LiVolsi VA. Thyroid carcinoma in patients with Graves’ disease: an institutional experience. Endocr Pathol. 2015;26:48-53. https://doi.org/10.1007/s12022-014-9343-6

Kadia BM, Dimala CA, Bechem NN, Aroke D. Concurrent hyperthyroidism and papillary thyroid cancer: a fortuitous and ambiguous case report from a resource-poor setting. BMC Res Notes. 2016;9:369. https://doi.org/10.1186/s13104-016-2178-0

Salih A, Kakamad F, Nihad H. Hyperfunctioning papillary thyroid carcinoma: A case report with literature review. Int J Surg Case Rep. 2016;26:202-4. https://doi.org/10.1016/j.ijscr.2016.08.001

Sharma SD, Kumar G, Guner K, Kaddour H. Hyperthyroidism in patients with thyroid cancer. Ear Nose Throat J. 2016;95:236-9. https://doi.org/10.1177/014556131609500612

Keskin C, Sahin M, Hasanov R, Aydogan BI, Demir O, Emral R, et al. Frequency of thyroid nodules and thyroid cancer in thyroidectomized patients with Graves’ disease. Arch Med Sci. 2019;16:302-7. https://doi.org/10.5114/aoms.2018.81136

Lima MJ, Soares V, Koch P, Silva A, Taveira-Gomes A. Autonomously hyperfunctioning cystic nodule harbouring thyroid carcinoma - Case report and literature review. Int J Surg Case Rep. 2018;42:287-9. https://doi.org/10.1016/j.ijscr.2018.01.002

Pandey RK, Sharma E, Roy S, Kandel S, Dahal S, Hossain MR, et al. Hot and malignant - a case of invasive papillary carcinoma in hyperthyroid patient with hot nodules. J Community Hosp Intern Med Perspect. 2018;8:220-2. https://doi.org/10.1080/20009666.2018.1490139

Shahbaz A, Fransawy Alkomos M, Mahendhar R, Nabi U, Riaz M, Sachmechi I. Follicular Variant of Papillary Thyroid Carcinoma Presented as Autonomous Functioning Thyroid Nodule: A Case Report and Review of Literature. Cureus. 2018;10:e3014. https://doi.org/10.7759/cureus.3014

Punitha S, Vedha pal jeyamani, Sindhu S, Bhuvaneshwari P, Arshath A. Papillary thyroid cancer patient with hyperthyroidism - a case study. Int J Res Pharm Sci. 2019;10:3178-81. https://doi.org/10.26452/ijrps.v10i4.1617

Tam AA, Ozdemir D, Alkan A, Yazicioglu O, Yildirim N, Kilicyazgan A, et al. Toxic nodular goiter and thyroid cancer: Is hyperthyroidism protective against thyroid cancer? Surgery. 2019;166:356-61. https://doi.org/10.1016/j.surg.2019.03.012

Mintegui G, Saccone S, Mendoza B. Carcinoma tiroideo en nódulo centellográfico hipercaptante: reporte de caso. Rev chil endocrinol diabetes. 2019;12:175-8.

Osorio C, Fernández A, Herrera K, Marrugo A, Ensucho C, Redondo K, Herrera F. Sensibilidad y especificidad de la citología obtenida mediante aspiración con aguja fina en el diagnóstico de las neoplasias foliculares de la glándula tiroides: Un estudio prospectivo. Rev Esp Patol. 2016;49:144-50. https://doi.org/10.1016/j.patol.2016.01.005

Herrera F, Redondo K, Osorio C, Grice J, Fernández A. Utilidad de la citología obtenida mediante aspiración con aguja fina en el diagnóstico de las neoplasias foliculares de la glándula tiroides en la E.S.E. Hospital Universitario del Caribe: Un estudio retrospectivo. Rev Colomb Cir. 2015;30:12-7.

Publicado

2021-06-11

Cómo citar

(1)
Osorio, C. .; Ballestas, J.; Barrios, D.; Arévalo, A.; Montaño, S.; Pérez, N.; Guardo, Y.; Oviedo, H.; Zambrano, V.; Redondo, K.; Herrera, F. Características clínicas Asociadas Al Hallazgo De cáncer De Tiroides Originado a Partir De nódulos Calientes En Pacientes Con Hipertiroidismo: Reporte De Un Caso Y revisión sistemática De La Literatura. Rev Colomb Cir 2021, 36, 682-695.

Número

Sección

Artículo de Revisión